// App-Quantinova.ai

POS0078 (2022) : COMPARING METHOTREXATE MONOTHERAPY WITH METHOTREXATE PLUS LEFLUNOMIDE COMBINATION THERAPY IN PSORIATIC ARTHRITIS: A RANDOMISED, PLACEBO-CONTROLLED, DOUBLE-BLIND CLINICAL TRIAL (COMPLETE-PsA)

Researchers

Presenter

  • M. L. M. Mulder

Principal Investigators

  • J. E. Vriezekolk

  • T. Van Hal

  • L. Nieboer

  • N. Den Broeder

  • E. M. G. J. De Jong

  • A. Den Broeder

  • F. Van den Hoogen

  • P. Helliwell

  • M. Wenink

Medical Centers

  • Sint Maartenskliniek, Rheumatology & Pharmacy, Ubbergen, Netherlands

  • Hengstdal , Sint Maartenskliniek, Nijmegen, Netherlands

  • Radboudumc Medical Centre, Dermatology, Nijmegen, Netherlands

  • Leeds University, Rheumatology, Leeds, United Kingdom

Locations

  • Netherlands

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

  • Dermatology

Disease

  • Psoriatic arthritis

Biomarkers

  • Malondialdehyde

Drug/Treatment

  • Methotrexate

  • leflunomide

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Controlled

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved